Kevin Priest
University of Adelaide
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kevin Priest.
BMJ | 2006
Catherine S. Gibson; Alastair H. MacLennan; Paul N. Goldwater; Eric Haan; Kevin Priest; Gustaaf A. Dekker
Abstract Objective To investigate the association between cerebral palsy and direct evidence for perinatal exposure to neurotropic viruses. Design Population based case-control study. Setting Adelaide Womens and Childrens Hospital Research Laboratory. Participants and main outcome measures Newborn screening cards of 443 white case patients with cerebral palsy and 883 white controls were tested for viral nucleic acids from enteroviruses and herpes viruses by using polymerase chain reaction. Herpes group A viruses included herpes simplex viruses 1 and 2 (HSV-1 and HSV-2), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpes virus 8 (HHV-8), and herpes group B viruses included varicella zoster virus (VZV) and human herpes viruses 6 and 7 (HHV-6 and HHV-7). Results The prevalence of viral nucleic acids in the control population was high: 39.8% of controls tested positive, and the prevalence was highest in preterm babies. The detection of herpes group B viral nucleic acids increased the risk of developing cerebral palsy (odds ratio 1.68, 95% confidence interval 1.09 to 2.59). Conclusions Perinatal exposure to neurotropic viruses is associated with preterm delivery and cerebral palsy.
Palliative Medicine | 2002
Roger W Hunt; Belinda Fazekas; Colin Luke; Kevin Priest; David Roder
Our aims were to determine the extent of coverage by designated palliative care services of the population of terminally ill cancer patients in South Australia, and to identify the types of patients who receive these services and the types who do not. All designated hospice and palliative care services in South Australia notified to the State Cancer Registry the identifying details of all their patients who died in 1999. This information was cross-referenced with the data for all cancer deaths (n=3086) recorded on the registry for 1999. We found that the level of coverage by designated palliative services of patients who died with cancer in 1999 was 68.2%. This methodology was previously used to show that the level of coverage had increased from 55.8% for cancer deaths in 1990 to 63.1% for those in 1993. Patients who died at home had the largest coverage by palliative services (74.7%), whereas patients who died in nursing homes had the lowest coverage (48.4%). Patients who did not receive care from these palliative services tended to be 80 years of age or older at death, country residents, those with a survival time from diagnosis of three months or less, and those diagnosed with a prostate, breast, or haematological malignancy. Gender, socioeconomic status of residential area, and race were not related to coverage by a designated palliative service, whereas migrants to Australia from the UK, Ireland, and Southern Europe were relatively high users of these services. We conclude that the high level of palliative care coverage observed in this study reflects widespread support for the establishment of designated services. When planning future care, special consideration should be given to the types of patients who most miss out on these services.
British Journal of Obstetrics and Gynaecology | 2010
Gustaaf A. Dekker; Annabelle Chan; Cg Luke; Kevin Priest; Merilyn Riley; Jane Halliday; James F. King; V Gee; M O’Neill; M Snell; V Cull; S Cornes
Please cite this paper as: Dekker G, Chan A, Luke C, Priest K, Riley M, Halliday J, King J, Gee V, O’Neill M, Snell M, Cull V, Cornes S. Risk of uterine rupture in Australian women attempting vaginal birth after one prior caesarean section: a retrospective population‐based cohort study. BJOG 2010;117:1358–1365.
British Journal of Obstetrics and Gynaecology | 2008
Catherine S. Gibson; Paul N. Goldwater; Alastair H. MacLennan; Eric Haan; Kevin Priest; Gustaaf A. Dekker
Objective To investigate the role of fetal viral infection in the development of a range of adverse pregnancy outcomes (APOs), including pregnancy‐induced hypertensive disorders (PIHD), antepartum haemorrhage (APH), birthweight <10th percentile (small for gestational age, SGA) and preterm birth (PTB).
Australian & New Zealand Journal of Obstetrics & Gynaecology | 2004
Adrian R. Heard; Gus Dekker; Annabelle Chan; Danielle J. Jacobs; Sophie A. Vreeburg; Kevin Priest
Background: There have been conflicting reports about pregnancy outcome in the hypertensive disorders of pregnancy. The present study was undertaken to examine outcomes using a population database.
Australian & New Zealand Journal of Obstetrics & Gynaecology | 2003
Danielle J. Jacobs; Sophie A. Vreeburg; Gus Dekker; Adrian R. Heard; Kevin Priest; Annabelle Chan
Objective: To identify risk factors for hypertension in pregnancy among South Australian women.
Australian & New Zealand Journal of Obstetrics & Gynaecology | 2009
Michael Djukic; Catherine S. Gibson; Alastair H. MacLennan; Paul N. Goldwater; Eric Haan; Gai McMichael; Kevin Priest; Gustaaf A. Dekker; William M. Hague; Annabelle Chan; Zbigniew Rudzki; Phillipa Van Essen; T. Yee Khong; Mark R. Morton; Enzo Ranieri; Heather Scott; Heather Tapp; Graeme Casey
Aim: Cytokine polymorphisms may alter the fetal inflammatory response, increasing susceptibility to cerebral palsy (CP). This study investigates associations between selected inflammatory mediator and cytokine gene polymorphisms (Toll‐like receptor‐4 (TLR‐4) Asp299Gly, interleukin‐6 G‐174C and interleukin‐4 C‐589T) and CP from 443 CP infants and 883 control infants. Results were correlated with viral nucleic acids in the same samples.
Pathology | 2005
Catherine S. Gibson; Alastair H. MacLennan; Zbigniew Rudzki; William M. Hague; Eric Haan; Phillipa Sharpe; Kevin Priest; Annabelle Chan; Gustaaf A. Dekker; Paul N. Goldwater; T. Yee Khong; Mark R. Morton; Enzo Ranieri; Heather Scott; Heather Tapp; Graeme Casey
Aims: To describe the prevalence of four inherited thrombophilias and their combinations for the first time in a large Caucasian Australian population. Methods: Newborn screening cards of 883 Caucasian babies born in South Australia in 1986–1999 were de‐identified and tested for the following inherited thrombophilic polymorphisms: factor V Leiden (G1691A), prothrombin gene mutation (G20210A), methylenetetrahydrofolate reductase gene (MTHFR) C677T and A1298C, as well as compound heterozygosity for the MTHFR polymorphisms. Results: The birth prevalences of heterozygosity and homozygosity for the four thrombophilic polymorphisms were: factor V Leiden 9.5% and 0.7%, prothrombin gene 4.1% and 0.2%, MTHFR C677T 37.3% and 12.4%, and MTHFR A1298C 38.3% and 11.8%, respectively. Compound heterozygosity for MTHFR C677T and A1298C was seen in 16.6% of the population. Overall, 64.2% and 24.5% of the population studied were homozygous and heterozygous, respectively, for at least one of the four polymorphisms studied. Conclusion: Inherited thrombophilic polymorphisms are common in the Caucasian Australian population. Knowledge of the background prevalence of these polymorphisms will allow further study of their associations in future disease research.
American Journal of Obstetrics and Gynecology | 2008
Catherine S. Gibson; Alastair H. MacLennan; Paul N. Goldwater; Eric Haan; Kevin Priest; Gustaaf A. Dekker
OBJECTIVE The objective of the study was to investigate the associations between infection, polymorphisms in the mannose-binding lectin gene (MBL), and cerebral palsy (CP). STUDY DESIGN This was a case-control study using deoxyribonucleic acid from newborn screening cards of 443 Caucasian CP cases and 883 Caucasian controls to screen for 6 polymorphisms within the MBL gene. These polymorphisms combine to create haplotypes with high (HYPA), intermediate (LYQA, LYPA), low (LXPA), and defective (HYPD, LYQC, LYPB) circulating MBL levels. RESULTS chi(2) Analyses demonstrated significant differences between CP cases and controls (less than 37 weeks chi(2) 14.99, P = .02; less than 32 weeks chi(2) 13.62, P = .02). The MBL haplotype LYPA was associated with CP at all gestations (odds ratio [OR] 1.57, 95% confidence interval [CI], 1.00 to 2.46), less than 37 weeks (OR 2.43, 95% CI, 1.41 to 4.18), and less than 32 weeks (OR 2.54, 95% CI, 1.34 to 4.76). LYPA was also associated with hemiplegic CP for babies born at less than 37 weeks (OR 2.77, 95% CI, 1.02 to 7.26) and less than 32 weeks (OR 4.48, 95% CI, 1.55 to 12.65). HYPD was associated with quadriplegic CP at all gestations (OR 3.47, 95% CI, 1.41 to 8.31) as well as for babies born at less than 32 weeks (OR 7.86, 95% CI, 1.67 to 29.48). Subanalysis on samples previously testing positive for exposure to viral infection demonstrated similar patterns of significance as those presented above, whereas analysis on samples negative for exposure to viral infection showed no positive associations between any of the MBL haplotypes and CP. Potential type I error from multiple analyses is a caveat. CONCLUSION MBL haplotypes LYPA or HYPD may be associated with an increased risk of CP in the presence of exposure to viral infection and may act as susceptibility factors for CP.
Australian & New Zealand Journal of Obstetrics & Gynaecology | 2004
Sophie A. Vreeburg; Danielle J. Jacobs; Gus Dekker; Adrian R. Heard; Kevin Priest; Annabelle Chan
Objective: To identify factors associated with adverse pregnancy outcomes among women with hypertension during pregnancy